Khan F - Search Results

1

Brevifoliol and its Analogs: A New Class of Anti-tubercular Agents.

Bhukya B, Alam S, Chaturvedi V, Trivedi P, Kumar S, Khan F, Negi AS, Srivastava SK. Bhukya B, et al. Among authors: khan f. Curr Top Med Chem. 2021;21(9):767-776. doi: 10.2174/1568026620666200528155236. Curr Top Med Chem. 2021. PMID: 32484109

2

Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity.

Yadav DK, Khan F, Negi AS. Yadav DK, et al. Among authors: khan f. J Mol Model. 2012 Jun;18(6):2513-25. doi: 10.1007/s00894-011-1265-3. Epub 2011 Oct 27. J Mol Model. 2012. PMID: 22038459

3

Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Kalani K, Yadav DK, Khan F, Srivastava SK, Suri N. Kalani K, et al. Among authors: khan f. J Mol Model. 2012 Jul;18(7):3389-413. doi: 10.1007/s00894-011-1327-6. Epub 2012 Jan 21. J Mol Model. 2012. PMID: 22271093

4

QSAR, docking and in vivo studies for immunomodulatory activity of isolated triterpenoids from Eucalyptus tereticornis and Gentiana kurroo.

Maurya A, Khan F, Bawankule DU, Yadav DK, Srivastava SK. Maurya A, et al. Among authors: khan f. Eur J Pharm Sci. 2012 Aug 30;47(1):152-61. doi: 10.1016/j.ejps.2012.05.009. Epub 2012 May 30. Eur J Pharm Sci. 2012. PMID: 22659375

5

Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents.

Ahmad I, Thakur JP, Chanda D, Saikia D, Khan F, Dixit S, Kumar A, Konwar R, Negi AS, Gupta A. Ahmad I, et al. Among authors: khan f. Bioorg Med Chem Lett. 2013 Mar 1;23(5):1322-5. doi: 10.1016/j.bmcl.2012.12.096. Epub 2013 Jan 9. Bioorg Med Chem Lett. 2013. PMID: 23369537

6

Synthesis of combretastatin A4 analogues on steroidal framework and their anti-breast cancer activity.

Parihar S, Kumar A, Chaturvedi AK, Sachan NK, Luqman S, Changkija B, Manohar M, Prakash O, Chanda D, Khan F, Chanotiya CS, Shanker K, Dwivedi A, Konwar R, Negi AS. Parihar S, et al. Among authors: khan f. J Steroid Biochem Mol Biol. 2013 Sep;137:332-44. doi: 10.1016/j.jsbmb.2013.02.009. Epub 2013 Feb 28. J Steroid Biochem Mol Biol. 2013. PMID: 23459143

7

QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.

Yadav DK, Kalani K, Khan F, Srivastava SK. Yadav DK, et al. Among authors: khan f. Med Chem. 2013 Dec;9(8):1073-84. doi: 10.2174/1573406411309080009. Med Chem. 2013. PMID: 23675978

8

In silico and in vivo anti-malarial studies of 18β glycyrrhetinic acid from Glycyrrhiza glabra.

Kalani K, Agarwal J, Alam S, Khan F, Pal A, Srivastava SK. Kalani K, et al. Among authors: khan f. PLoS One. 2013 Sep 24;8(9):e74761. doi: 10.1371/journal.pone.0074761. eCollection 2013. PLoS One. 2013. PMID: 24086367 Free PMC article.

9

Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7.

Yadav DK, Kalani K, Singh AK, Khan F, Srivastava SK, Pant AB. Yadav DK, et al. Among authors: khan f. Curr Med Chem. 2014;21(9):1160-70. doi: 10.2174/09298673113206660330. Curr Med Chem. 2014. PMID: 24180274

10

4-Hydroxy-α-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli.

Dwivedi GR, Upadhyay HC, Yadav DK, Singh V, Srivastava SK, Khan F, Darmwal NS, Darokar MP. Dwivedi GR, et al. Among authors: khan f. Chem Biol Drug Des. 2014 Apr;83(4):482-92. doi: 10.1111/cbdd.12263. Chem Biol Drug Des. 2014. PMID: 24267788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,343 results

Search Page